Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2625 of 3284 entries
View as:

A Study to Assess Safety,and Tolerability of 2 Doses of AZD9773 (CytoFab™) in Japanese With Severe Sepsis/Septic Shock

Phase: N/A Priority: Normal
NCT ID: NCT01144624 Org: User:
Start: 07/31/10 End: 08/31/11 Due: 08/31/12

Achievement of Goal Resting Heart Rate on B-blockers in Patients With Stable Angina and Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01321242 Org: User:
Start: 04/30/11 End: 08/31/11 Due: 08/31/12

A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives

Phase: N/A Priority: Normal
NCT ID: NCT01110525 Org: User:
Start: 05/31/10 End: 10/31/10 Due: 10/31/11

OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)

Phase: N/A Priority: Normal
NCT ID: NCT00076089 Org: User:
Start: 12/31/03 End: 12/31/05 Due: 12/31/06

Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic Obstruct

Phase: N/A Priority: Normal
NCT ID: NCT01426893 Org: User:
Start: 10/31/11 End: 03/31/12 Due: 03/31/13

D2212C00002 J-Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT02036580 Org: User:
Start: 01/31/14 End: 11/30/15 Due: 11/30/16

Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)

Phase: N/A Priority: Normal
NCT ID: NCT04031898 Org: User:
Start: 05/07/19 End: 12/31/19 Due: 12/31/20

Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

Phase: N/A Priority: Normal
NCT ID: NCT00229697 Org: User:
Start: 10/31/03 End: 06/30/15 Due: 06/30/16

A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

Phase: N/A Priority: Normal
NCT ID: NCT05629585 Org: User:
Start: 11/28/22 End: 01/30/30 Due: 01/30/31

A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

Phase: N/A Priority: Normal
NCT ID: NCT05104866 Org: User:
Start: 10/18/21 End: 12/31/25 Due: 12/31/26

To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01185314 Org: User:
Start: 09/30/10 End: 07/31/11 Due: 07/31/12

Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05070312 Org: User:
Start: 08/23/21 End: 02/07/22 Due: 02/07/23

Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)

Phase: N/A Priority: Normal
NCT ID: NCT00654225 Org: User:
Start: 10/31/02 End: 03/31/05 Due: 03/31/06

AZD9668 Relative Bioavailability

Phase: N/A Priority: Normal
NCT ID: NCT01034982 Org: User:
Start: 11/30/09 End: 12/31/09 Due: 12/31/10

Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT00960791 Org: User:
Start: 07/31/09 End: 09/30/09 Due: 09/30/10

DAPA - Egypt Study

Phase: N/A Priority: Normal
NCT ID: NCT03624803 Org: User:
Start: 03/09/19 End: 03/30/20 Due: 03/30/21

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

Phase: N/A Priority: Normal
NCT ID: NCT00384176 Org: User:
Start: 08/30/06 End: 08/19/15 Due: 08/19/16

Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00631189 Org: User:
Start: 10/31/07 End: 10/31/08 Due: 10/31/09

Iressa Versus Docetaxel (Taxotere)

Phase: N/A Priority: Normal
NCT ID: NCT00076388 Org: User:
Start: 02/29/04 End: 10/31/07 Due: 10/31/08

An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01876849 Org: User:
Start: 12/31/03 End: 07/31/08 Due: 07/31/09

Symbicort Onset of Action 1

Phase: N/A Priority: Normal
NCT ID: NCT00646620 Org: User:
Start: 04/30/03 End: 09/30/03 Due: 09/30/04

Effect on Weight Loss of Exenatide Versus Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00375492 Org: User:
Start: 09/30/06 End: 02/29/08 Due: 02/28/09

Investigation Into the Correlation of Plasma Hs-CRP Concentrations and Cardiovascular Risk in Korean Population

Phase: N/A Priority: Normal
NCT ID: NCT00819273 Org: User:
Start: 03/31/09 End: 08/31/09 Due: 08/31/10

Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01369563 Org: User:
Start: 08/31/11 End: 05/31/12 Due: 05/31/13

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05932641 Org: User:
Start: 07/31/23 End: 12/05/24 Due: 12/05/25